Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$130.71
+2.9%
$126.26
$99.14
$133.10
$331.09B0.388.34 million shs12.75 million shs
NIKE, Inc. stock logo
NKE
NIKE
$93.94
-0.7%
$97.39
$88.66
$128.68
$141.79B1.089.47 million shs5.30 million shs
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$162.55
0.0%
$159.46
$141.45
$164.32
$383.64B0.446.97 million shs7.09 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.06%+1.32%+1.35%+5.68%+8.99%
NIKE, Inc. stock logo
NKE
NIKE
+0.64%-0.21%+0.93%-6.10%-24.08%
The Procter & Gamble Company stock logo
PG
Procter & Gamble
+0.67%+3.58%+1.49%+4.47%+3.96%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.6642 of 5 stars
2.33.03.34.13.22.51.9
NIKE, Inc. stock logo
NKE
NIKE
4.4419 of 5 stars
3.33.04.21.52.41.71.3
The Procter & Gamble Company stock logo
PG
Procter & Gamble
4.4663 of 5 stars
2.35.04.21.62.62.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.58
Moderate Buy$131.250.41% Upside
NIKE, Inc. stock logo
NKE
NIKE
2.58
Moderate Buy$116.2623.76% Upside
The Procter & Gamble Company stock logo
PG
Procter & Gamble
2.67
Moderate Buy$169.764.44% Upside

Current Analyst Ratings

Latest NKE, PG, and MRK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$180.00 ➝ $185.00
4/23/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$168.00 ➝ $170.00
4/22/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$172.00 ➝ $171.00
4/22/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$175.00 ➝ $182.00
4/18/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$135.00
4/12/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$165.00 ➝ $168.00
4/11/2024
NIKE, Inc. stock logo
NKE
NIKE
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$110.00 ➝ $113.00
4/8/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$140.00 ➝ $143.00
4/5/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$135.00
4/3/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$170.00 ➝ $172.00
3/28/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$139.00 ➝ $142.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$60.12B5.51$3.13 per share41.71$14.85 per share8.80
NIKE, Inc. stock logo
NKE
NIKE
$51.22B2.77$3.87 per share24.29$9.43 per share9.96
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$82.01B4.68$7.42 per share21.92$20.99 per share7.74

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$365M$0.14933.6413.221.650.61%9.33%3.61%4/25/2024 (Confirmed)
NIKE, Inc. stock logo
NKE
NIKE
$5.07B$3.4027.6323.901.8110.14%39.41%14.92%7/4/2024 (Estimated)
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$14.65B$6.1226.5623.353.2818.00%33.91%13.39%7/26/2024 (Estimated)

Latest NKE, PG, and MRK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/25/2024N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.12$2.07-$0.05N/A$15.21 billion$15.78 billion  
4/19/2024Q3 23
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$1.42$1.52+$0.10$1.52$20.43 billion$20.20 billion      
3/21/2024Q3 2024
NIKE, Inc. stock logo
NKE
NIKE
$0.69$0.98+$0.29$1.19$12.28 billion$12.43 billion    
2/1/2024Q4 2023
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-$0.09$0.03+$0.12$0.54$14.49 billion$14.63 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.082.36%+6.08%2,200.00%13 Years
NIKE, Inc. stock logo
NKE
NIKE
$1.481.58%+11.23%43.53%21 Years
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$4.032.48%+6.21%65.85%68 Years

Latest NKE, PG, and MRK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/9/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
quarterly$1.00652.57%4/18/20244/19/20245/15/2024
2/8/2024
NIKE, Inc. stock logo
NKE
NIKE
quarterly$0.371.43%3/1/20243/4/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.89
1.25
1.00
NIKE, Inc. stock logo
NKE
NIKE
0.63
2.74
1.89
The Procter & Gamble Company stock logo
PG
Procter & Gamble
0.49
0.69
0.48

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
NIKE, Inc. stock logo
NKE
NIKE
64.25%
The Procter & Gamble Company stock logo
PG
Procter & Gamble
65.77%

Insider Ownership

CompanyInsider Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.09%
NIKE, Inc. stock logo
NKE
NIKE
0.50%
The Procter & Gamble Company stock logo
PG
Procter & Gamble
0.17%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
72,0002.53 billion2.53 billionOptionable
NIKE, Inc. stock logo
NKE
NIKE
83,7001.51 billion1.50 billionOptionable
The Procter & Gamble Company stock logo
PG
Procter & Gamble
107,0002.36 billion2.36 billionOptionable

NKE, PG, and MRK Headlines

SourceHeadline
Procter & Gamble (NYSE:PG) Stock Price Up 0.1% After Analyst UpgradeProcter & Gamble (NYSE:PG) Stock Price Up 0.1% After Analyst Upgrade
marketbeat.com - April 25 at 7:07 PM
Procter & Gamble (NYSE:PG) Reaches New 1-Year High Following Analyst UpgradeProcter & Gamble (NYSE:PG) Reaches New 1-Year High Following Analyst Upgrade
marketbeat.com - April 25 at 3:44 PM
Procter & Gamble (NYSE:PG) Given New $185.00 Price Target at ArgusProcter & Gamble (NYSE:PG) Given New $185.00 Price Target at Argus
marketbeat.com - April 25 at 2:02 PM
Dividend Legends: 3 Stocks With Over 100 Years of PayoutsDividend Legends: 3 Stocks With Over 100 Years of Payouts
investorplace.com - April 25 at 12:07 PM
The Procter & Gamble Company (NYSE:PG) Position Boosted by Alaska Permanent Fund CorpThe Procter & Gamble Company (NYSE:PG) Position Boosted by Alaska Permanent Fund Corp
marketbeat.com - April 25 at 10:02 AM
The Procter & Gamble Company (NYSE:PG) Insider Balaji Purushothaman Sells 28,369 SharesThe Procter & Gamble Company (NYSE:PG) Insider Balaji Purushothaman Sells 28,369 Shares
insidertrades.com - April 25 at 7:02 AM
Procter & Gamble (NYSE:PG) Stock Price Down 0.5% After Insider SellingProcter & Gamble (NYSE:PG) Stock Price Down 0.5% After Insider Selling
americanbankingnews.com - April 25 at 2:37 AM
Members Capital Advisors Inc. Has $260,000 Stock Holdings in The Procter & Gamble Company (NYSE:PG)Members Capital Advisors Inc. Has $260,000 Stock Holdings in The Procter & Gamble Company (NYSE:PG)
marketbeat.com - April 24 at 10:45 PM
Balaji Purushothaman Sells 28,369 Shares of The Procter & Gamble Company (NYSE:PG) StockBalaji Purushothaman Sells 28,369 Shares of The Procter & Gamble Company (NYSE:PG) Stock
marketbeat.com - April 24 at 9:14 PM
Procter & Gamble (NYSE:PG)  Shares Down 0.5%  on Insider SellingProcter & Gamble (NYSE:PG) Shares Down 0.5% on Insider Selling
marketbeat.com - April 24 at 12:36 PM
Is Procter & Gamble Stock Appropriately Priced At $160?Is Procter & Gamble Stock Appropriately Priced At $160?
forbes.com - April 24 at 10:41 AM
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on ItProcter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com - April 24 at 10:06 AM
Gillette Venus Supports The Saltwater Collective to Launch New Size-inclusive Swimwear CollectionGillette Venus Supports The Saltwater Collective to Launch New Size-inclusive Swimwear Collection
businesswire.com - April 24 at 8:00 AM
Procter & Gamble (NYSE:PG) Given New $170.00 Price Target at BarclaysProcter & Gamble (NYSE:PG) Given New $170.00 Price Target at Barclays
americanbankingnews.com - April 24 at 5:46 AM
The Procter & Gamble Company (NYSE:PG) CEO R. Alexandra Keith Sells 855 Shares of StockThe Procter & Gamble Company (NYSE:PG) CEO R. Alexandra Keith Sells 855 Shares of Stock
americanbankingnews.com - April 24 at 4:58 AM
R. Alexandra Keith Sells 855 Shares of The Procter & Gamble Company (NYSE:PG) StockR. Alexandra Keith Sells 855 Shares of The Procter & Gamble Company (NYSE:PG) Stock
insidertrades.com - April 24 at 4:48 AM
Procter & Gamble (NYSE:PG) Shares Up 0.5% After Analyst UpgradeProcter & Gamble (NYSE:PG) Shares Up 0.5% After Analyst Upgrade
americanbankingnews.com - April 24 at 3:14 AM
Schnieders Capital Management LLC Reduces Stake in The Procter & Gamble Company (NYSE:PG)Schnieders Capital Management LLC Reduces Stake in The Procter & Gamble Company (NYSE:PG)
marketbeat.com - April 23 at 11:17 PM
A Closer Look at 9 Analyst Recommendations For Procter & GambleA Closer Look at 9 Analyst Recommendations For Procter & Gamble
markets.businessinsider.com - April 23 at 7:28 PM
Procter & Gamble continues gain for seven straight sessionsProcter & Gamble continues gain for seven straight sessions
msn.com - April 23 at 7:28 PM
3 Stocks to Protect Your Portfolio in a Market Downturn: April Edition3 Stocks to Protect Your Portfolio in a Market Downturn: April Edition
investorplace.com - April 23 at 2:46 PM
Barclays Raises Procter & Gamble (NYSE:PG) Price Target to $170.00Barclays Raises Procter & Gamble (NYSE:PG) Price Target to $170.00
marketbeat.com - April 23 at 11:57 AM
Procter & Gamble (NYSE:PG) Trading Up 0.5% After Analyst UpgradeProcter & Gamble (NYSE:PG) Trading Up 0.5% After Analyst Upgrade
marketbeat.com - April 23 at 11:29 AM
7 Dividend Stocks to Hold Onto During the Current Market Turbulence7 Dividend Stocks to Hold Onto During the Current Market Turbulence
investorplace.com - April 23 at 9:41 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Merck & Co., Inc. logo

Merck & Co., Inc.

NYSE:MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
NIKE logo

NIKE

NYSE:NKE
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. It also sells a line of performance equipment and accessories comprising bags, sport balls, socks, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. In addition, the company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel; and licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. It sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.
Procter & Gamble logo

Procter & Gamble

NYSE:PG
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.